Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractInvestigating RGS proteins in yeast    Next AbstractArbuscular Mycorrhizal Fungi and Plant Chemical Defence: Effects of Colonisation on Aboveground and Belowground Metabolomes »

Cell Signal


Title:Isolation and characterization of a novel human RGS mutant displaying gain-of-function activity
Author(s):Hill C; Brownlie Z; Davey J; Milligan G; Ladds G;
Address:"Department of Biological Sciences, University of Warwick, Coventry, CV4 7AL, UK. Claire.L.Hill@warwick.ac.uk"
Journal Title:Cell Signal
Year:2008
Volume:20071018
Issue:2
Page Number:323 - 336
DOI: 10.1016/j.cellsig.2007.10.016
ISSN/ISBN:0898-6568 (Print) 0898-6568 (Linking)
Abstract:"Regulator of G protein signaling (RGS) proteins play a crucial role in the adaptation of cells to stimulation by G protein-coupled receptors via heterotrimeric G proteins. Alterations in RGS function have been implicated in a wide range of disease states, leading to many researchers focusing on controlling the action of these regulatory proteins. Previous studies have centered on reducing or inhibiting the action of RGS proteins, utilizing inactive mutants or small molecular RGS inhibitors. Here we describe the isolation and characterization of a novel human RGS4 mutant which displays enhanced or gain-of-function (GOF) activity. RGS4(S30C) demonstrates GOF activity both in an in vivo yeast-based signalling pathway and in vitro against the Galpha(o1) subunit contained in an alpha(2A)-adrenoreceptor-Galpha(o1)(C351I) fusion protein. Mutational analysis of serine 30 identified a number of alternative substitutions that result in GOF activity. GOF activity was retained upon transposition of the serine 30-cysteine mutation to the equivalent serine residue in human RGS16. As with previously identified GOF mutants, RGS4(S30C/S30F/S30K) demonstrate increased steady state protein levels, however these mutants also demonstrate enhanced GAP activity through an additional mechanism distinct from the increased protein content. The identification of human RGS mutants with GOF activity may provide novel therapeutic agents for the treatment of signaling-based diseases and the ability to transpose these mutations to other human RGS proteins extends their application to multiple pathways"
Keywords:"Amino Acid Sequence Cell Line Conserved Sequence DNA Mutational Analysis Dose-Response Relationship, Drug Epinephrine/pharmacology GTP Phosphohydrolases/metabolism GTP-Binding Protein alpha Subunits, Gi-Go/metabolism Genes, Reporter Humans Molecular Seque;"
Notes:"MedlineHill, Claire Brownlie, Zoe Davey, John Milligan, Graeme Ladds, Graham eng C17789/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom Research Support, Non-U.S. Gov't England 2007/11/23 Cell Signal. 2008 Feb; 20(2):323-36. doi: 10.1016/j.cellsig.2007.10.016. Epub 2007 Oct 18"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 22-09-2024